Stay updated on CPX-351 and Ivosidenib in IDH1 AML Clinical Trial

Sign up to get notified when there's something new on the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.
    Difference
    0.3%
    Check dated 2024-10-03T04:36:59.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The website has been updated to version v2.11.0, while a previous notice regarding delays in displaying study record information has been removed.
    Difference
    4%
    Check dated 2024-09-25T22:15:45.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    ClinicalTrials.gov is addressing delays in displaying study record information, and the website has been updated to version 2.10.5, replacing the previous version 2.10.3.
    Difference
    4%
    Check dated 2024-09-18T16:26:12.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3.
    Difference
    0.3%
    Check dated 2024-09-04T04:14:39.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.3%
    Check dated 2024-08-13T22:47:43.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The website has been updated to version 2.10.0, introducing new features for viewing and comparing study record versions.
    Difference
    6%
    Check dated 2024-07-23T14:18:44.000Z thumbnail image

Stay in the know with updates to CPX-351 and Ivosidenib in IDH1 AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page.